Acanthoic acid induces cell apoptosis through activation of the p38 MAPK pathway in HL-60 human promyelocytic leukaemia

► We examined the molecular mechanisms involved in acanthoic acid-induced apoptosis in HL-60 cells. ► Acanthoic acid (ACAN) induced apoptosis in HL-60 cells via activation of caspase-3 and inhibition of Bcl-xL. ► A specific p38 MAPK inhibitor (SB203580) significantly blocks ACAN-induced apoptosis an...

Full description

Saved in:
Bibliographic Details
Published inFood chemistry Vol. 135; no. 3; pp. 2112 - 2117
Main Authors Kim, Kil-Nam, Ham, Young Min, Moon, Ji-Young, Kim, Min-Jin, Jung, Yong-Hwan, Jeon, You-Jin, Lee, Nam Ho, Kang, Nalae, Yang, Hye-Mi, Kim, Daekyung, Hyun, Chang-Gu
Format Journal Article
LanguageEnglish
Published Kidlington Elsevier Ltd 01.12.2012
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:► We examined the molecular mechanisms involved in acanthoic acid-induced apoptosis in HL-60 cells. ► Acanthoic acid (ACAN) induced apoptosis in HL-60 cells via activation of caspase-3 and inhibition of Bcl-xL. ► A specific p38 MAPK inhibitor (SB203580) significantly blocks ACAN-induced apoptosis and cell viability. ► Thus, the activation of p38 MAPK may play an important role in ACAN-induced apoptosis. The present study was designed to evaluate the molecular mechanisms of the action of acanthoic acid (ACAN) from Acanthopanax koreanum (Araliaceae) against HL-60 human promyelocytic leukaemia cells. ACAN reduced the proliferation of HL-60 cells in a dose- and time-dependent manner accompanied by the induction of apoptosis. Possible mechanisms of ACAN-induced apoptosis were also examined. The results showed that ACAN-induced the phosphorylation of members of the mitogen-activated protein kinase (MAPK) family, c-Jun N-terminal kinase (JNK), p38 MAPK (p38), and extracellular signal-regulated kinase (ERK). A specific p38 MAPK inhibitor (SB203580) significantly blocked ACAN-induced apoptosis and cell viability, whereas an ERK inhibitor (PD98059) and JNK inhibitor (SP600125) had no effect. Moreover, ACAN induced the cleavage of caspase-3 and poly-ADP-ribose polymerase (PARP), and decreased the level of Bcl-xL, but these effects were inhibited by SB203580 pre-treatment. These results strongly suggest that ACAN may have cancer chemopreventive and therapeutic potential, due to its ability to activate the p38 MAPK-mediated signalling pathways.
Bibliography:http://dx.doi.org/10.1016/j.foodchem.2012.05.067
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0308-8146
1873-7072
DOI:10.1016/j.foodchem.2012.05.067